Cite
HARVARD Citation
Kudo, T. et al. (n.d.). Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial. Lancet oncology. 18 (5), pp. 631-639. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kudo, T. et al. (n.d.). Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial. Lancet oncology. 18 (5), pp. 631-639. [Online].